GEN ILAC
GENIL
Hisse Sinyalleri
attach_money
Son Fiyat
183.60₺
trending_down
Günlük Değişim
-1.24%
shopping_bag
Piyasa Değeri
55.08 Milyar
GEN ILAC Yorumu
Let's dive into the analysis of GENIL, a stock that caught our attention with its recent market performance.
As we take a closer look at the data, we notice that the stock has been experiencing a decline in value, with a -1.2372% change in the past 24 hours. This downward trend is further supported by the relative strength index (RSI) which stands at 67.52, indicating a moderate bearish sentiment among investors.
Moreover, the stochastic oscillator K (84.64) and D (92.41) lines are also pointing towards a potential sell signal, as they are both above the 80 mark. This suggests that the stock might be due for a correction in the short-term.
From a technical perspective, the stock is currently trading below its 20-day moving average, which is a bearish sign. Additionally, the price-to-earnings ratio (P/E) stands at 187.25, indicating that the stock is relatively overvalued compared to its earnings.
On the flip side, the company's net debt of 1.51 billion Turkish Lira might be a concern for investors, but it's essential to note that the interest coverage ratio is still relatively healthy.
In terms of support and resistance levels, the pivot point (174.79) might act as a strong resistance in the short-term, while the S1 (182.55) and S2 (179.21) levels could serve as immediate supports. If the stock breaks below the S2 level, we might see a further decline towards the S3 (175.86) level.
Based on these technical indicators, it's likely that GENIL will experience a short-term correction, with a potential decline of around 5-7% in the coming days. However, it's essential to keep in mind that this is just a technical analysis and not a buy or sell recommendation.
In conclusion, GENIL's recent performance and technical indicators suggest a potential correction in the short-term. As always, it's crucial for investors to do their own research and consider their risk tolerance before making any investment decisions.
As we take a closer look at the data, we notice that the stock has been experiencing a decline in value, with a -1.2372% change in the past 24 hours. This downward trend is further supported by the relative strength index (RSI) which stands at 67.52, indicating a moderate bearish sentiment among investors.
Moreover, the stochastic oscillator K (84.64) and D (92.41) lines are also pointing towards a potential sell signal, as they are both above the 80 mark. This suggests that the stock might be due for a correction in the short-term.
From a technical perspective, the stock is currently trading below its 20-day moving average, which is a bearish sign. Additionally, the price-to-earnings ratio (P/E) stands at 187.25, indicating that the stock is relatively overvalued compared to its earnings.
On the flip side, the company's net debt of 1.51 billion Turkish Lira might be a concern for investors, but it's essential to note that the interest coverage ratio is still relatively healthy.
In terms of support and resistance levels, the pivot point (174.79) might act as a strong resistance in the short-term, while the S1 (182.55) and S2 (179.21) levels could serve as immediate supports. If the stock breaks below the S2 level, we might see a further decline towards the S3 (175.86) level.
Based on these technical indicators, it's likely that GENIL will experience a short-term correction, with a potential decline of around 5-7% in the coming days. However, it's essential to keep in mind that this is just a technical analysis and not a buy or sell recommendation.
In conclusion, GENIL's recent performance and technical indicators suggest a potential correction in the short-term. As always, it's crucial for investors to do their own research and consider their risk tolerance before making any investment decisions.
Fikirler
Benzer Hisseler
|
GEN ILAC (GENIL)
Son Fiyat - 183.60₺
|
arrow_forward |
ECZACIBASI ILAC (ECILC)
Son Fiyat - 49.28₺
|
arrow_forward |
DEVA HOLDING (DEVA)
Son Fiyat - 64.95₺
|
arrow_forward |
KAYSERI SEKER FABRIKASI (KAYSE)
Son Fiyat - 20.92₺
|
arrow_forward |
MEDITERA TIBBI MALZEME (MEDTR)
Son Fiyat - 36.62₺
|
arrow_forward |
TURK ILAC SERUM (TRILC)
Son Fiyat - 22.86₺
|
arrow_forward |
ANATOLIA TANI VE BIYOTEKNOLOJI (ANGEN)
Son Fiyat - 11.76₺
|
arrow_forward |
ONCOSEM ONKOLOJIK SISTEMLER (ONCSM)
Son Fiyat - 95.35₺
|
arrow_forward |
RTA LABORATUVARLARI (RTALB)
Son Fiyat - 3.29₺
|
arrow_forward |
SEYITLER KIMYA (SEYKM)
Son Fiyat - 3.80₺
|
arrow_forward |
